Tecan U.S. Compliance Difficulties Dampen North American Q3 Sales
This article was originally published in The Gray Sheet
Executive Summary
Tecan is taking steps to bolster its regulatory processes, following compliance problems that emerged during an FDA inspection of the firm's Durham, N.C. facility
You may also be interested in...
Wrist Device, Medical Software Web Claims Draw Warning Letters
Carpal Kinetics' Wristrac for treatment of Carpal Tunnel Syndrome requires a 510(k) because the device differs from other nonpowered orthopedic traction devices, FDA informs the firm in a warning letter released Oct. 26
Wrist Device, Medical Software Web Claims Draw Warning Letters
Carpal Kinetics' Wristrac for treatment of Carpal Tunnel Syndrome requires a 510(k) because the device differs from other nonpowered orthopedic traction devices, FDA informs the firm in a warning letter released Oct. 26
Roche Readies Tecan Clinical Workstation 510(k) After Warning Letter
Roche Diagnostics is preparing to submit a 510(k) for the Tecan clinical workstation, following receipt of a related 1warning letter